Detail
Článek
Článek online
FT
Medvik - BMČ
  • Je něco špatně v tomto záznamu ?

Key Drivers and Facilitators of the Choice to Use mHealth Technology in People With Neurological Conditions: Observational Study

S. Simblett, M. Pennington, M. Quaife, E. Theochari, P. Burke, G. Brichetto, J. Devonshire, S. Lees, A. Little, A. Pullen, A. Stoneman, S. Thorpe, J. Weyer, A. Polhemus, J. Novak, E. Dawe-Lane, D. Morris, M. Mutepua, C. Odoi, E. Wilson, T. Wykes

. 2022 ; 6 (5) : e29509. [pub] 20220523

Jazyk angličtina Země Kanada

Typ dokumentu časopisecké články

Perzistentní odkaz   https://www.medvik.cz/link/bmc22017110

BACKGROUND: There is increasing interest in the potential uses of mobile health (mHealth) technologies, such as wearable biosensors, as supplements for the care of people with neurological conditions. However, adherence is low, especially over long periods. If people are to benefit from these resources, we need a better long-term understanding of what influences patient engagement. Previous research suggests that engagement is moderated by several barriers and facilitators, but their relative importance is unknown. OBJECTIVE: To determine preferences and the relative importance of user-generated factors influencing engagement with mHealth technologies for 2 common neurological conditions with a relapsing-remitting course: multiple sclerosis (MS) and epilepsy. METHODS: In a discrete choice experiment, people with a diagnosis of MS (n=141) or epilepsy (n=175) were asked to select their preferred technology from a series of 8 vignettes with 4 characteristics: privacy, clinical support, established benefit, and device accuracy; each of these characteristics was greater or lower in each vignette. These characteristics had previously been emphasized by people with MS and or epilepsy as influencing engagement with technology. Mixed multinomial logistic regression models were used to establish which characteristics were most likely to affect engagement. Subgroup analyses explored the effects of demographic factors (such as age, gender, and education), acceptance of and familiarity with mobile technology, neurological diagnosis (MS or epilepsy), and symptoms that could influence motivation (such as depression). RESULTS: Analysis of the responses to the discrete choice experiment validated previous qualitative findings that a higher level of privacy, greater clinical support, increased perceived benefit, and better device accuracy are important to people with a neurological condition. Accuracy was perceived as the most important factor, followed by privacy. Clinical support was the least valued of the attributes. People were prepared to trade a modest amount of accuracy to achieve an improvement in privacy, but less likely to make this compromise for other factors. The type of neurological condition (epilepsy or MS) did not influence these preferences, nor did the age, gender, or mental health status of the participants. Those who were less accepting of technology were the most concerned about privacy and those with a lower level of education were prepared to trade accuracy for more clinical support. CONCLUSIONS: For people with neurological conditions such as epilepsy and MS, accuracy (ie, the ability to detect symptoms) is of the greatest interest. However, there are individual differences, and people who are less accepting of technology may need far greater reassurance about data privacy. People with lower levels of education value greater clinician involvement. These patient preferences should be considered when designing mHealth technologies.

Citace poskytuje Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc22017110
003      
CZ-PrNML
005      
20220720100114.0
007      
ta
008      
220718s2022 xxc f 000 0|eng||
009      
AR
024    7_
$a 10.2196/29509 $2 doi
035    __
$a (PubMed)35604761
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a xxc
100    1_
$a Simblett, Sara $u Psychology Department, King's College London, London, United Kingdom $1 https://orcid.org/0000000280758238
245    10
$a Key Drivers and Facilitators of the Choice to Use mHealth Technology in People With Neurological Conditions: Observational Study / $c S. Simblett, M. Pennington, M. Quaife, E. Theochari, P. Burke, G. Brichetto, J. Devonshire, S. Lees, A. Little, A. Pullen, A. Stoneman, S. Thorpe, J. Weyer, A. Polhemus, J. Novak, E. Dawe-Lane, D. Morris, M. Mutepua, C. Odoi, E. Wilson, T. Wykes
520    9_
$a BACKGROUND: There is increasing interest in the potential uses of mobile health (mHealth) technologies, such as wearable biosensors, as supplements for the care of people with neurological conditions. However, adherence is low, especially over long periods. If people are to benefit from these resources, we need a better long-term understanding of what influences patient engagement. Previous research suggests that engagement is moderated by several barriers and facilitators, but their relative importance is unknown. OBJECTIVE: To determine preferences and the relative importance of user-generated factors influencing engagement with mHealth technologies for 2 common neurological conditions with a relapsing-remitting course: multiple sclerosis (MS) and epilepsy. METHODS: In a discrete choice experiment, people with a diagnosis of MS (n=141) or epilepsy (n=175) were asked to select their preferred technology from a series of 8 vignettes with 4 characteristics: privacy, clinical support, established benefit, and device accuracy; each of these characteristics was greater or lower in each vignette. These characteristics had previously been emphasized by people with MS and or epilepsy as influencing engagement with technology. Mixed multinomial logistic regression models were used to establish which characteristics were most likely to affect engagement. Subgroup analyses explored the effects of demographic factors (such as age, gender, and education), acceptance of and familiarity with mobile technology, neurological diagnosis (MS or epilepsy), and symptoms that could influence motivation (such as depression). RESULTS: Analysis of the responses to the discrete choice experiment validated previous qualitative findings that a higher level of privacy, greater clinical support, increased perceived benefit, and better device accuracy are important to people with a neurological condition. Accuracy was perceived as the most important factor, followed by privacy. Clinical support was the least valued of the attributes. People were prepared to trade a modest amount of accuracy to achieve an improvement in privacy, but less likely to make this compromise for other factors. The type of neurological condition (epilepsy or MS) did not influence these preferences, nor did the age, gender, or mental health status of the participants. Those who were less accepting of technology were the most concerned about privacy and those with a lower level of education were prepared to trade accuracy for more clinical support. CONCLUSIONS: For people with neurological conditions such as epilepsy and MS, accuracy (ie, the ability to detect symptoms) is of the greatest interest. However, there are individual differences, and people who are less accepting of technology may need far greater reassurance about data privacy. People with lower levels of education value greater clinician involvement. These patient preferences should be considered when designing mHealth technologies.
655    _2
$a časopisecké články $7 D016428
700    1_
$a Pennington, Mark $u Psychology Department, King's College London, London, United Kingdom $1 https://orcid.org/0000000213928700
700    1_
$a Quaife, Matthew $u Health Economics Department, London School of Hygiene & Tropical Medicine, London, United Kingdom $1 https://orcid.org/0000000192911511
700    1_
$a Theochari, Evangelia $u Neurosciences Department, King's College Hospital, London, United Kingdom $1 https://orcid.org/0000000248991670
700    1_
$a Burke, Patrick $u Remote Assessment of Disease and Relapse in Central Nervous System Disorders Patient Advisory Board, King's College London, London, United Kingdom $1 https://orcid.org/0000000325476374
700    1_
$a Brichetto, Giampaolo $u Remote Assessment of Disease and Relapse in Central Nervous System Disorders Patient Advisory Board, King's College London, London, United Kingdom $u Italian Multiple Sclerosis Society and Foundation, Rome, Italy $1 https://orcid.org/0000000320263572
700    1_
$a Devonshire, Julie $u Remote Assessment of Disease and Relapse in Central Nervous System Disorders Patient Advisory Board, King's College London, London, United Kingdom $1 https://orcid.org/0000000342188323
700    1_
$a Lees, Simon $u Remote Assessment of Disease and Relapse in Central Nervous System Disorders Patient Advisory Board, King's College London, London, United Kingdom $1 https://orcid.org/0000000151407394
700    1_
$a Little, Ann $u Remote Assessment of Disease and Relapse in Central Nervous System Disorders Patient Advisory Board, King's College London, London, United Kingdom $u International Bureau for Epilepsy, Dublin, Ireland $1 https://orcid.org/0000000295878507
700    1_
$a Pullen, Angie $u Remote Assessment of Disease and Relapse in Central Nervous System Disorders Patient Advisory Board, King's College London, London, United Kingdom $u Epilepsy Action, Leeds, United Kingdom $1 https://orcid.org/0000000167358953
700    1_
$a Stoneman, Amanda $u Remote Assessment of Disease and Relapse in Central Nervous System Disorders Patient Advisory Board, King's College London, London, United Kingdom $u Epilepsy Action, Leeds, United Kingdom $1 https://orcid.org/0000000280036067
700    1_
$a Thorpe, Sarah $u Remote Assessment of Disease and Relapse in Central Nervous System Disorders Patient Advisory Board, King's College London, London, United Kingdom $1 https://orcid.org/0000000189733777
700    1_
$a Weyer, Janice $u Remote Assessment of Disease and Relapse in Central Nervous System Disorders Patient Advisory Board, King's College London, London, United Kingdom $1 https://orcid.org/0000000278386260
700    1_
$a Polhemus, Ashley $u Merck Sharp & Dohme Information Technology, Prague, Czech Republic $1 https://orcid.org/0000000250565785
700    1_
$a Novak, Jan $u Psychology Department, King's College London, London, United Kingdom $u Merck Sharp & Dohme Information Technology, Prague, Czech Republic $u Faculty of Science, Charles University, Prague, Czech Republic $1 https://orcid.org/0000000155452723
700    1_
$a Dawe-Lane, Erin $u Psychology Department, King's College London, London, United Kingdom $1 https://orcid.org/0000000284796696
700    1_
$a Morris, Daniel $u Psychology Department, King's College London, London, United Kingdom $1 https://orcid.org/0000000151187344
700    1_
$a Mutepua, Magano $u Psychology Department, King's College London, London, United Kingdom $1 https://orcid.org/0000000257618894
700    1_
$a Odoi, Clarissa $u Psychology Department, King's College London, London, United Kingdom $u South London and Maudsley Biomedical Research Centre, London, United Kingdom $1 https://orcid.org/0000000261329307
700    1_
$a Wilson, Emma $u Psychology Department, King's College London, London, United Kingdom $1 https://orcid.org/0000000344138338
700    1_
$a Wykes, Til $u Psychology Department, King's College London, London, United Kingdom $1 https://orcid.org/0000000258818003
773    0_
$w MED00209098 $t JMIR formative research $x 2561-326X $g Roč. 6, č. 5 (2022), s. e29509
856    41
$u https://pubmed.ncbi.nlm.nih.gov/35604761 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y - $z 0
990    __
$a 20220718 $b ABA008
991    __
$a 20220720100110 $b ABA008
999    __
$a ind $b bmc $g 1816443 $s 1168352
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2022 $b 6 $c 5 $d e29509 $e 20220523 $i 2561-326X $m JMIR formative research $n JMIR Form Res $x MED00209098
LZP    __
$a Pubmed-20220718

Najít záznam

Citační ukazatele

Možnosti archivace